tm logo
SYNTHORIN
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 31 Jan 2022

Last Applicant/ Owned by

11099 North Torrey Pines Road, Suite 190

La Jolla

CA

92037

Serial Number

87695246 filed on 22nd Nov 2017

Registration Number

N/A

Correspondent Address

Karen Lim

Karen Lim

151 West 42nd Street, 17th Floor

New York NY 10036

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SYNTHORIN

protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeu Read More

Classification Information


Class [005]
Pharmaceutical Products


protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, oncology including immuno-oncology, cardiovascular and metabolic diseases, and infectious diseases; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from cancer and autoimmune disorders; Protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, therapeutic agents in the nature of cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, anti-infectives, analgesics, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics

Mark Details


Serial Number

No 87695246

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SYNX 2001819

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
31st Jan 2022ABANDONMENT - NO USE STATEMENT FILED
31st Jan 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
18th May 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th May 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
17th May 2021SOU EXTENSION 5 GRANTED
05th May 2021SOU TEAS EXTENSION RECEIVED
05th May 2021SOU EXTENSION 5 FILED
05th Nov 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03rd Nov 2020SOU TEAS EXTENSION RECEIVED
03rd Nov 2020SOU EXTENSION 4 FILED